CYP2J2 and cardiac hypertrophy: Conversely, transgenic over-expression of human CYP2J2 in murine cardiomyocytes enhances EpFA production which preserves cardiac function in ischemia-reperfusion injury, diabetic cardiomyopathy, and attenuates arrythmia susceptibility in cardiac hypertrophy.